Shree Ganesh Bio-Tech (India) Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported revenue was INR 204.75 million compared to INR 155.63 million a year ago. Net income was INR 10.32 million compared to INR 6.82 million a year ago.

Basic earnings per share from continuing operations was INR 0.03 compared to INR 0.015 a year ago. Diluted earnings per share from continuing operations was INR 0.026 compared to INR 0.017 a year ago.